Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

T Cell Activation and Clonal Selection

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Recurrent Carotid Blowout Syndrome Managed by Infratemporal Internal Carotid Ligation: A Case Report.

Case reports in otolaryngology·2026

Same author

High affinity is insufficient for strong B cell activation by HIV broadly neutralising antibodies.

NPJ vaccines·2026

Same author

Author Correction: Titration of RAS alters senescent state and influences tumour initiation.

Nature·2026

Same author

Efficacy of Combined Septal Extension and Derotation Grafts in Asian Rhinoplasty: A Quantitative Analysis of Tip Projection and Stability.

Aesthetic surgery journal·2026

Same author

An imbalance between CD80 and CD86 levels and CD4 regulatory T cell number and transendocytosis function exists in the liver in autoimmune hepatitis.

Clinical and experimental immunology·2026

Same author

3D-Printed Surgical Guide in Nasal Bone Osteotomy.

Plastic and reconstructive surgery·2026

Search research articles

Related Experiment Video

Updated: Jun 13, 2025

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

Rigid, bivalent CTLA-4 binding to CD80 is required to disrupt the cis CD80/PD-L1 interaction.

Maximillian A Robinson¹, Alan Kennedy¹, Carolina T Orozco²

¹Institute of Immunity and Transplantation, Pears Building, Rowland Hill St, London NW3 2PP, UK.

|September 15, 2024

Summary

Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) binding to CD80, not PD-L1, is crucial for immunotherapy. CTLA-4

Keywords:

More Related Videos

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry

Published on: January 6, 2017

Ligand Nano-cluster Arrays in a Supported Lipid Bilayer

Ligand Nano-cluster Arrays in a Supported Lipid Bilayer

Published on: April 23, 2017

Related Experiment Videos

Last Updated: Jun 13, 2025

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry

Published on: January 6, 2017

Ligand Nano-cluster Arrays in a Supported Lipid Bilayer

Ligand Nano-cluster Arrays in a Supported Lipid Bilayer

Published on: April 23, 2017

Area of Science:

Immunology
Molecular Biology
Cancer Research

Background:

Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and Programmed cell death protein 1 (PD-1) are critical immune checkpoints targeted in cancer immunotherapy.
These pathways are linked by a cis-interaction between CD80 and PD-L1, the respective ligands for CTLA-4 and PD-1.
CTLA-4-mediated trans-endocytosis of CD80 reverses this cis-interaction, but the mechanism of selective CD80 removal is not fully understood.

Purpose of the Study:

To elucidate the mechanism by which CTLA-4 selectively removes CD80 without affecting PD-L1.
To investigate the role of CTLA-4 molecule rigidity and bivalency in regulating CD80-PD-L1 interactions.
To compare the effects of soluble CTLA-4 and CTLA-4 trans-endocytosis on PD-L1 release.

Main Methods:

Investigated CTLA-4-CD80 interactions in the presence of PD-L1.
Assessed the impact of CTLA-4 molecule rigidity and bivalency on CD80 orientation and PD-L1 binding.
Compared PD-L1 release induced by soluble CTLA-4 versus CTLA-4 trans-endocytosis under varying CD80 and PD-L1 expression levels.

Main Results:

CTLA-4 binding to CD80 is not impeded by PD-L1, and CTLA-4 does not directly displace PD-L1.
CTLA-4 molecule rigidity and bivalency are essential for orienting CD80, thereby preventing PD-L1 interactions.
Soluble CTLA-4 released PD-L1 only at specific CD80/PD-L1 expression levels, while trans-endocytosis released PD-L1 under all conditions tested.

Conclusions:

PD-L1 release from CD80 is mediated by the orientation and bivalent cross-linking of membrane proteins by CTLA-4.
CTLA-4 trans-endocytosis of CD80 effectively promotes PD-L1 availability, suggesting a key mechanism in immune regulation.
Understanding these molecular interactions provides insights into optimizing CTLA-4-based immunotherapies.